Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma

NCT04637269 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: anti-BCMA CAR-T

Sponsor

Xinqiao Hospital of Chongqing

Collaborators

[object Object]